Sign In
Buy SAGE
$8.68
+0 (+0%)
At Close: Oct 30, 2025
Sage Therapeutics to Present at Upcoming November Investor Conferences
06:30am, Monday, 02'nd Nov 2020
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $SAGE #Sage--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives
Sage Therapeutics May Have The Juice That's Worth The Speculative Squeeze
10:04am, Monday, 26'th Oct 2020
Sage Therapeutics has shown impressive results on the charts YTD, where shareholders have enjoyed +169% gains since the selloff. The stock has bounced away from support nicely 5 times since then, with
